Study tour “Austrian Life Science Innovation Ecosystem” in Vienna
The Human Technopole Centre for Innovation and Technology Transfer (CITT) continues its international promotion activities by learning about foreign innovation ecosystems.
Last November 2023, the CITT organised a study tour to meet the leading players in basic and applied research within the Austrian ecosystem, with the support of the Italian Embassy in Vienna and the Italian Trade Agency.
ABOUT THE STUDY TOUR
Over two intense days, the CITT team traveled with a delegation of TTOs and professionals engaged in enhancing research results within Italian research centers, universities, and research hospitals to investigate how innovation is generated in Austria and which players are involved.
The goals of the visit, led by Fabio Terragni – member of the HT Management Committee delegate for tech transfer – have been multiple: understand the peculiarities of the Austrian innovation ecosystem, meet its active players, learn about good practices and the reference framework (standards, incentives, available funding), also to identify potential areas of teamwork among the two countries.
PROGRAMME
- On November 29, honored by the welcome of H.E. ambassador Stefano Beltrame, the delegation gathered at Palazzo Metternich (the Italian Embassy in Vienna) to meet and hear from the most prominent drivers of innovation in Austria – FFG, Lisavienna, Vienna Business Agency (VBA), Austrian Business Agency (ABA) – about several topics, i.e., the relevant framework, available funding, and best practices in the life sciences. Presentations ended with insights about two successful startups, Solgate and Proxygen. Fabio Terragni, member of the HT management committee and delegate for tech transfer, presented Human Technopole and the activities related to tech transfer.
- On November 29 and 30, the delegation visited three major research centres: the Vienna BioCenter (IMBA-GMI, INiTS, University of Vienna, Medical University of Vienna), ISTA, and CeMM; all leading players in basic and applied research within the Austrian ecosystem.
We thank the Italian Embassy in Vienna and the Italia Trade Agency for their invaluable support in organizing the initiative.
Big thanks to Angelo Nuzzo (FFG), Elvira Kainersdorfer (LISAvienna), Birgit Reiter-Braunwieser (ABA), Christian Frey and Daniel Chaldek (VBA), Enrico Girardi (Solgate), Matthias Brand (Proxygen), Markus Pietzka (INiTS), Raphaela Freidl (University of Vienna), Andrea Kolbus (Medical University of Vienna), Markus Wanko and Alexander Schwartz (xista), Prudence Donovan and Giulio Superti-Furga (CeMM) for sharing their expertise and leaving us with so many takeaways.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.